葉酸の世界市場：市場シェア・規模・動向の分析と将来予測

世界の葉酸市場は今後、4.1%のCAGR (複合年間成長率) で成長し続け、2026年には10億4000万米ドルの規模に達する見通しです。現代は生活習慣の変化などからビタミン欠乏症、さらには葉酸欠乏症となる人々が多く、それが市場成長の一因ともなっています。

第1章 分析の概要と範囲

第2章 エグゼクティブ・サマリー

第3章 葉酸市場の分析

• 葉酸：産業概況
• 葉酸市場のバリューチェーン・流通分析
• メラミン市場のダイナミクス
  • 市場促進要因の分析
  • 市場抑制要因／課題の分析
  • 市場機会の分析
• 葉酸の生産量の動向 (過去7年間分)
• 産業分析：ポーターのファイブフォースモデル
• 葉酸市場：PEST分析
• 葉酸市場の参入企業：ヒートマップ分析
• 企業ランキング分析

第4章 葉酸市場：市場規模とその予測、用途別

• 分析概略
• 医薬品
• 食品・飲料
• ニュートラシューティカルズ
• その他

第5章 葉酸市場：市場規模とその予測、地域別

• 分析概略
• 北米 (米国、カナダ)
• 欧州 (ドイツ、英国、フランス、ベルギー、イタリア、スペイン)
• アジア太平洋地域 (中国、インド、日本、韓国、オーストラリア)
• ラテンアメリカ (ブラジル、メキシコ)
• 中東・アフリカ (サウジアラビア、UAE)

第6章 企業プロファイル

• Hebei Jiheng Group Pharmacy Co Ltd
  • 概要
  • 財務指標
  • 製品の相互比較
  • 近年の動向
• Shandong Xinfa Pharmaceutical Co., Ltd.
• Changzhou Niutang Chemical Plant Co. Ltd.
• Jiangxi Tianxin Pharmaceutical Co. Ltd.
• Xinjiang Wujiaqu Xingnong Cycle Chemical Co. Ltd.
• Emcure Pharmaceuticals Ltd.
• Medicamen Biotech Ltd.
• Zydus Pharmaceuticals Ltd.
• Koninklijke DSM N.V.
• BASF SE

The global folic acid market size estimated to be worth of USD 1.04 billion by 2026 and is projected to grow at a CAGR of 4.1 % over the forecast period.

Folic acid, is a form of water-soluble vitamin. Folate is found naturally in food, and folic acid is its synthetic form. Okra, fruits, asparagus, mushrooms, meats, tomato juice, orange juice, lettuce, spinach, and broccoli are some of the natural sources of folate. It is used for the proper functioning as well as the development of the human body. It is instrumental in the production of the human body DNA.

Folic acid is abundantly available in natural sources. However due to various reasons such as malabsorption, poor dietary habits, prolonged illness, and side effects of drugs, many people witness a deficiency of the vitamin. Development of enhanced drug delivery systems which effectively deliver the vitamin in the human body combined with the rising cases of folic acid deficiency is expected to benefit the market demand.

Folic acid finds various health applications and is used for treating folate deficiency which his caused due to low blood folate levels. The symptoms of the disease include anemia, and the inability to absorb nutrients properly. Other diseases that can be prevented and treated with folic acid include kidney dialysis, liver disease, alcoholism as well as ulcerative colitis.

Folic acid is particularly useful in treating diseases related to pregnancy. Pregnant women are advised to intake folic acid for the prevention of miscarriage. It is also advised to intake folic acid to reduce the occurrence of defects such as spina bifida, a case in which the back and spine do not close.

Folic acid is also used to treat cervical cancer as well as colon cancer. It can be effective in treating stroke among other heart diseases, and can be effective in lowering the levels of homocysteine, a chemical found in human blood. High homocysteine levels result in high prevalence of heart disease. The rise in cases of heart diseases across the globe and effectiveness of folic acid in treating them is expected to benefit the overall folic acid market growth.

Folic acid is used to treat a variety of ailments relating to age. They are used to treat Alzheimer's disease, memory loss, hearing loss as well as AMD or age - related macular disease. IT is also used to reduce the aging signs, weak bones, restless leg syndrome, nerve pain, sleep problems, depression, vitiligo, muscle pain and rare diseases such as the Fragile - X syndrome. It is also used to offset the harmful effects of medicines such as methotrexate and lometrexol. The rise in geriatric population across the globe is expected to benefit the global folic acid market demand over the forecast period.

Some of the notable market participants include BASF SE, Koninklijke DSM N.V., Zydus Pharmaceuticals Ltd., Medicamen Biotech Ltd., Emcure Pharmaceuticals Ltd., Jiangxi Tianxin Pharmaceutical Co. Ltd., Xinjiang Wujiaqu Xingnong Cycle Chemical Co. Ltd., Changzhou Niutang Chemical Plant Co. Ltd., Shandong Xinfa Pharmaceutical Co., Ltd., and Hebei Jiheng Group Pharmacy Co Ltd among others.

Table of Contents

1. Overview and Scope

• 1.1. Research goal & scope
• 1.2. Research assumptions
• 1.3. Research Methodology
  • 1.3.1. Primary data sources
  • 1.3.2. Secondary data sources
• 1.4. Key take-away
• 1.5. Stakeholders

2. Executive Summary

• 2.1. Market Definition
• 2.2. Market Segmentation

3. Folic acid Market Insights

• 3.1. Folic acid industry snapshot
• 3.2. Folic acid value chain & distribution analysis
• 3.3. Folic acid Market dynamics
  • 3.3.1. Folic acid Market driver analysis
  • 3.3.2. Folic acid Market restraint/challenges analysis
  • 3.3.3. Folic acid Market opportunity analysis
• 3.4. Folic acid Production Trend Analysis, 2011 - 2017
• 3.5. Industry analysis - Porter's five force
• 3.6. Folic acid Market PEST analysis
• 3.7. Folic acid Industry Participants Heat Map Analysis
• 3.8. Competitive company ranking analysis, 2017

4. Folic acid Market Size and Forecast, By Application (Kilo Tons; USD Million)

• 4.1. Key Findings
• 4.2. Pharmaceuticals
• 4.3. Food & beverage
• 4.4. Nutraceuticals
• 4.5. Others

5. Folic acid Market Size and Forecast by Regions (Kilo Tons, USD Million)

• 5.1. Key findings
• 5.2. North America
  • 5.2.1. U.S.
  • 5.2.2. Canada
• 5.3. Europe
  • 5.3.1. Germany
  • 5.3.2. UK
  • 5.3.3. France
  • 5.3.4. Belgium
  • 5.3.5. Italy
  • 5.3.6. Spain
• 5.4. Asia Pacific
  • 5.4.1. China
  • 5.4.2. India
  • 5.4.3. Japan
  • 5.4.4. South Korea
  • 5.4.5. Australia
• 5.5. Latin America
  • 5.5.1. Brazil
  • 5.5.2. Mexico
• 5.6. Middle East & Africa
  • 5.6.1. Saudi Arabia
  • 5.6.2. UAE

6. Company Profiles

• 6.1. Hebei Jiheng Group Pharmacy Co Ltd
  • 6.1.1. Overview
  • 6.1.2. Financials
  • 6.1.3. Product Benchmarking
  • 6.1.4. Recent Developments
• 6.2. Shandong Xinfa Pharmaceutical Co., Ltd.
  • 6.2.1. Overview
  • 6.2.2. Financials
  • 6.2.3. Product Benchmarking
  • 6.2.4. Recent Developments
• 6.3. Changzhou Niutang Chemical Plant Co. Ltd.
  • 6.3.1. Overview
  • 6.3.2. Financials
  • 6.3.3. Product Benchmarking
  • 6.3.4. Recent Developments
• 6.4. Jiangxi Tianxin Pharmaceutical Co. Ltd.
  • 6.4.1. Overview
  • 6.4.2. Financials
  • 6.4.3. Product Benchmarking
  • 6.4.4. Recent Developments
• 6.5. Xinjiang Wujiaqu Xingnong Cycle Chemical Co. Ltd.
  • 6.5.1. Overview
  • 6.5.2. Financials
  • 6.5.3. Product Benchmarking
  • 6.5.4. Recent Developments
• 6.6. Emcure Pharmaceuticals Ltd.
  • 6.6.1. Overview
  • 6.6.2. Financials
  • 6.6.3. Product Benchmarking
  • 6.6.4. Recent Developments
• 6.7. Medicamen Biotech Ltd.
  • 6.7.1. Overview
  • 6.7.2. Financials
  • 6.7.3. Product Benchmarking
  • 6.7.4. Recent Developments
• 6.8. Zydus Pharmaceuticals Ltd.
  • 6.8.1. Overview
  • 6.8.2. Financials
  • 6.8.3. Product Benchmarking
  • 6.8.4. Recent Developments
• 6.9. Koninklijke DSM N.V.
  • 6.9.1. Overview
  • 6.9.2. Financials
  • 6.9.3. Product Benchmarking
  • 6.9.4. Recent Developments
• 6.10. BASF SE
  • 6.10.1. Overview
  • 6.10.2. Financials
  • 6.10.3. Product Benchmarking
  • 6.10.4. Recent Developmentsa